Chapter 66

Reference

  1. An T, Tabaczka P. 2004. The use of polarization microscopy in the diagnosis of Pneumocystis pneumonia. Arch Pathol Lab Med 128:363-364.
  2. Anonymous. 1990. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323:1500-1504.
  3. Bartlett MS, Edlind TD, Lee CH, et al. 1994. Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice. Antimicrob Agents Chemother 38:1834-1837.
  4. Bartlett MS, Queener SF, Shaw MM, et al. 1994. Pneumocystis carinii is resistant to imidazole antifungal agents. Antimicrob Agents Chemother 38:1859-1861.
  5. Bartlett MS, Smith JWM. 1991. Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev 4:137-149.
  6. Beard CB, Carter JL, Keely SP, et al. 2000. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 6:265-272.
  7. Botha WS, Ban Rensburg IBJ. 1979. Pneumocystosis: a chronic respiratory distress syndrome in the dog. J South Afr Vet Assoc 50:173-179.
  8. Bozzette SA, Finkelstein DM, Spector SA, et al. 1995. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 332:693-699.
  9. Brownlie SE. 1990. A retrospective study of diagnosis in 109 cases of canine lower respiratory disease. J Small Anim Pract 31:371-376.
  10. Cabanes FJ, Roura X, Majo N, et al. 2000. Pneumocystis carinii pneumonia in a Yorkshire terrier dog. Med Mycol 38:451-453.
  11. Calderón E, De La Horra C, Montes-Cano MA, et al. 2004. Genotypic resistance to sulfamide drugs among patients with Pneumocystis jiroveci pneumonia. Med Clin (Barc) 122:617-619.
  12. Canfield PJ, Church DB, Malik R. 1993. Pneumocystis pneumonia in a dog. Aust Vet Pract 23:150-154.
  13. Cere N, Polack B, Chanteloup NK, et al. 1997. Natural transmission of Pneumocystis carinii in nonimmunosuppressed animals: early contagiousness of experimentally infected rabbits (Oryctolagus cuniculus). J Clin Microbiol 35:2670-2672.
  14. Chan C, Montaner J, Lefebvre EA, et al. 1999. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. J Infect Dis 180:369-376.
  15. Copland JW. 1974. Canine pneumonia caused by Pneumocystis carinii. Aust Vet J 50:515-518.
  16. Cregan P, Yamamoto A, Lum A, et al. 1990. Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 28:2432-2436.
  17. Cunningham-Rundles C, Knight AK. 2007. Common variable immune deficiency: reviews, continued puzzles, and a new registry. Immunol Res 38:78-86.
  18. Daly KR, Huang L, Morris A, et al. 2006. Antibody response to Pneumocystis jirovecii major surface glycoprotein. Emerg Infect Dis 12:1231-1237
  19. Daly KR, Koch J, Levin L, et al. 2004. Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci. Emerg Infect Dis 10:848-854.
  20. Delclaux C, Zahar JR, Amraoui G, et al. 1999. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients. Clin Infect Dis 29:670-672.
  21. Douzinas EE, Flevari K, Andrianakis I, et al. 2010. Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency. Scand J Infect Dis 42:76-78.
  22. English K, Peters SE, Maskell DJ, et al. 2001. DNA analysis of Pneumocystis infecting a Cavalier King Charles spaniel. J Eukaryot Microbiol Suppl:106S.
  23. Farrow BR, Watson ADJ, Hartley WJ, et al. 1972. Pneumocystis pneumonia in the dog. J Comp Pathol 82:447-453.
  24. Flori P, Bellete B, Durand F, et al. 2004. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol 53:603-607.
  25. Furuta T, Nogami S, Kojima S, et al. 1994. Spontaneous Pneumocystis carinii infection in the dog with naturally acquired demodicosis. Vet Rec 134:423-424.
  26. Greene CE, Chandler FW. 1990. Pneumocystosis, pp 854-861. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  27. Greene CE, Singer MJ, Brockus C, et al. 2002. Unpublished data. University of Georgia, Athens, GA.
  28. Hagiwara Y, Fujiwara S, Takai H, et al. 2001. Pneumocystis carinii pneumonia in a Cavalier King Charles spaniel. J Vet Med Sci 63:349-351.
  29. Hong ST, Park KH, Lee SH. 1992. Susceptibility of various animals to Pneumocystis carinii infection. Korean J Parasitol 30:277-281.
  30. Hughes WT. 1995. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol 8:247-252.
  31. Hughes WT. 1998. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review. Clin Infect Dis 27:191-204.
  32. Hughes WT. 2003. Pneumocystis carinii vs Pneumocystis jiroveci: another misnomer (response to Stringer et al.). Emerg Infect Dis 9:276-277.
  33. Jensen TK, Boye M, Bille-Hansen V. 2001. Application of fluorescent in situ hybridization for specific diagnosis of Pneumocystis carinii pneumonia in foals and pigs. Vet Pathol 38:269-274.
  34. Kelly MN, Shellito JE. 2010. Current understanding of Pneumocystis immunology. Future Microbiol 5:43-65.
  35. Kirberger RM, Lobetti RG. 1998. Radiographic aspects of Pneumocystis carinii pneumonia in the miniature dachshund. Vet Radiol Ultrasound 39:313-317.
  36. Kitada K, Oka S, Kimura S, et al. 1991. Detection of Pneumocystis carinii sequences by polymerase chain reaction: animal models and clinical application to noninvasive specimens. J Clin Microbiol 29:1985-1990.
  37. Kondo H, Hikita M, Ito M, et al. 2000. Immunohistochemical study of Pneumocystis carinii infection in pigs: evaluation of Pneumocystis pneumonia and a retrospective investigation. Vet Rec 147:544-549.
  38. Kovacs JA, Gill VJ, Meshnick S, et al. 2001. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 286:2450-2459.
  39. Lobetti R. 2000. Common variable immunodeficiency in miniature dachshunds affected with Pneumocystis carinii pneumonia. J Vet Diagn Invest 12:39-45.
  40. Lobetti R. 2001. Pneumocystis carinii infection in miniature dachshunds. Compend Cont Educ Pract Vet 23:320-327.
  41. Lobetti RG, Leisewitz AL, Spencer JA. 1996. Pneumocystis carinii in the miniature dachshund: case report and literature review. J Small Anim Pract 37:280-285.
  42. Lu JJ, Chen CH, Bartlett S, et al. 1995. Comparison of six different PCR methods for detection of Pneumocystis carinii. J Clin Microbiol 33:2785-2788.
  43. Masur H. 1992. Prevention and treatment of Pneumocystis pneumonia. N Engl J Med 327:1853-1860.
  44. McCully RM, Lloyd J, Kuys D, et al. 1979. Canine Pneumocystis pneumonia. J South Afr Vet Assoc 50:207-213.
  45. Morris A, Lundgren JD, Sasur H, et al. 2004. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 10:1713-1740.
  46. Mortier E, Pouchot J, Bossi P, et al. 1995. Maternal-fetal transmission of Pneumocystis carinii in human immunodeficiency virus infection. N Engl J Med 332:825.
  47. Ng VL, Virani NA, Chaisson RE, et al. 1990. Rapid detection of Pneumocystis carinii using a direct fluorescent monoclonal antibody stain. J Clin Microbiol 28:2228-2233.
  48. Palca J. 1995. A storm over steroid therapy. Science 250:1196-1198.
  49. Ponce CA, Gallo M, Bustamante R, et al. 2010. Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin Infect Dis 50:347-353.
  50. Ramsey IK, Foster A, McKay J, et al. 1997. Pneumocystis carinii pneumonia in two Cavalier King Charles spaniels. Vet Rec 140:372-373.
  51. Roux P, Lavrard I, Porrot JL, et al. 1994. Usefulness of PCR for detection of Pneumocystis carinii DNA. J Clin Microbiol 32:2324-2326.
  52. Settnes OP, Hasselager E. 1984. Occurrence of Pneumocystis carinii, Delanoe & Delanoe, 1912, in dogs and cats in Denmark. Nord Vet Med 36:179-181.
  53. Shimizu A, Kimura F, Kimura S. 1985. Occurrence of Pneumocystis carinii in animals in Japan. Jap J Vet Sci 47:309-311.
  54. Settnes OP, Henriksen SA. 1989. Pneumocystis carinii in large domestic animals in Denmark. A preliminary report. Acta Vet Scand 30:437-440.
  55. Stoeckle M, Tennenberg A. 1995. Atovaquone for Pneumocystis carinii pneumonia. Ann Intern Med 122:314-315.
  56. Stringer JR, Beard CB, Miller RF, et al. 2002. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 8:891-896.
  57. Sukura A, Laakkonen J, Rudback E. 1997. Occurrence of Pneumocystis carinii in canine distemper. Acta Vet Scand 38:201-205.
  58. Sukura A, Saari S, Jarvinen A. 1996. Pneumocystis carinii pneumonia in dogs. A diagnostic challenge. J Vet Diagn Invest 8:124-130.
  59. Thomas CF Jr, Limper AH. 2004. Pneumocystis pneumonia. N Engl J Med 350:2487-2498.
  60. Twedten HW, Langhorn RF, Beneke ES. 1974. Systemic Pneumocystis carinii infection in a dog. J Am Anim Hosp Assoc 10:592-594.
  61. Watson PJ, Wotton P, Eastwood J, et al. 2006. Immunoglobulin deficiency in Cavalier King Charles spaniels with Pneumocystis pneumonia. J Vet Intern Med 20:523-527.
  62. Watts JC, Chandler FW. 1991. Evolving concepts of infection by Pneumocystis carinii. Pathol Annu 26(Part 1):93-138.
  63. 62a. Weir EC, Cashmore AR, Dreyer RN, et al. 1982. Pharmacology and toxicity of a potent "Nonclassical" 2,4-diamino quinazoline folate antagonist, trimetrexate, in normal dogs. Cancer Res 42:1696-1702.
  64. Yuezhong Y, Li Z, Baoping T. 1996. Pneumonia in cats caused by Pneumocystis carinii purified from mouse lungs. Vet Parasitol 61:171-175.